The Hospira Foundation has donated $5 million to the University of Chicago Medicine to create the Hospira Foundation Professorship in Oncology.
The Hospira Foundation Professor will be a key leader in advancing the University of Chicago Medicine’s cancer research objectives, which include discovering new and better therapies capable of transforming the body’s ability to overcome cancer, creating genetically precise treatments that target patients’ cancer cells, and developing a new standard of patient care that delivers a higher quality of life.
The Hospira Foundation was the philanthropic affiliate of Hospira, Inc., which was acquired by Pfizer Inc. in September 2015.
“This generous gift from the Hospira Foundation will carry on Hospira’s legacy and boost the University’s efforts to make a difference in the lives of those with cancer,” said Kenneth S. Polonsky, MD, Executive Vice President for Medical Affairs at the University of Chicago and Dean of Biological Sciences Division and Pritzker School of Medicine. ■